Fatigue is one of the most commonly reported health complaints across all age groups. For many people, tiredness is transient and explained by straightforward causes: poor sleep, high stress, or a demanding period of work or illness. 

For others, the fatigue is persistent, disproportionate to effort, and resistant to rest. When tiredness becomes a chronic state rather than a temporary one, the explanation often lies deeper than lifestyle alone.

One of the most important and frequently overlooked biological roots of persistent fatigue is mitochondrial dysfunction. 

Mitochondria are the primary energy-producing structures within every cell, responsible for converting nutrients into the adenosine triphosphate (ATP) that powers every biological process in the body. 

When mitochondrial function declines, the consequences extend well beyond tiredness, touching cognitive performance, physical recovery, immune resilience, and the pace of biological ageing.

What Are Mitochondria and Why Does Their Function Matter?

Mitochondria are membrane-enclosed organelles found in virtually every cell in the human body, with the exception of red blood cells. 

Each cell contains hundreds to thousands of mitochondria, depending on the energy demands of that tissue. Cells with the highest metabolic requirements, including cardiac muscle cells, neurons, and skeletal muscle fibres, carry the greatest mitochondrial density.

The primary function of mitochondria is to produce adenosine triphosphate (ATP) through a process called oxidative phosphorylation. 

This process takes place across the inner mitochondrial membrane and involves a series of protein complexes known as the electron transport chain (ETC). 

Electrons derived from the breakdown of glucose, fatty acids, and amino acids pass through these complexes, driving the production of ATP that fuels cellular activity.

Beyond energy production, mitochondria regulate calcium signalling, govern apoptosis (programmed cell death), and play a central role in the production and management of reactive oxygen species (ROS). 

When mitochondrial function declines, all of these processes are affected simultaneously, which is why the consequences of mitochondrial dysfunction are so broad and varied.

What Causes Mitochondrial Dysfunction?

Mitochondrial dysfunction does not arise from a single cause. Several converging factors contribute to a decline in mitochondrial efficiency and capacity, many of which are part of normal biological ageing but are accelerated by specific environmental and lifestyle conditions.

Oxidative stress

The mitochondria themselves are a primary source of reactive oxygen species as a byproduct of ATP production. 

When ROS production exceeds the cell’s antioxidant capacity, oxidative damage accumulates in mitochondrial DNA, membranes, and the protein complexes of the electron transport chain. 

Mitochondrial DNA is particularly vulnerable to oxidative damage due to its proximity to the ETC and its limited repair mechanisms.

Ageing

Mitochondrial function declines progressively with age. 

The accumulation of mitochondrial DNA mutations, a reduction in the efficiency of the electron transport chain, and a decline in mitophagy (the process by which damaged mitochondria are cleared and replaced) all contribute to a progressive reduction in cellular energy output across the lifespan.

Chronic inflammation

Sustained inflammatory signalling disrupts mitochondrial membrane integrity and impairs electron transport chain function. 

The relationship between mitochondrial dysfunction and chronic inflammation is bidirectional: dysfunctional mitochondria produce more ROS, which amplifies inflammatory signalling, which further damages mitochondrial function.

Nutrient deficiencies

Mitochondrial function depends on an array of micronutrients as cofactors for enzymatic processes. 

Deficiencies in B vitamins, magnesium, coenzyme Q10, and NAD+ precursors directly impair the efficiency of ATP synthesis and mitochondrial repair pathways.

Chronic psychological and physiological stress

Sustained elevation of cortisol and other stress hormones places additional demands on cellular energy production while simultaneously impairing mitochondrial biogenesis, the process by which new mitochondria are generated within cells.

7 Signs That Chronic Fatigue May Indicate Mitochondrial Dysfunction

The signs of mitochondrial dysfunction are not limited to fatigue alone. 

As mitochondria are present in every cell and their output underpins every biological process, dysfunction tends to manifest across multiple systems simultaneously. 

Together, these seven signs can offer a clearer picture than looking at any one of them on its own.

1. Persistent Fatigue That Does Not Resolve With Rest

The defining characteristic of fatigue rooted in mitochondrial dysfunction is its resistance to recovery. 

Unlike normal tiredness, which resolves with adequate sleep and rest, fatigue driven by impaired ATP production persists regardless of how much rest a person gets. 

This is because the problem is not depletion of energy reserves but a fundamental reduction in the cell’s capacity to produce energy in the first place.

Research by Booth et al., documented reduced mitochondrial complex activity in patients with chronic fatigue syndrome, providing a biological basis for the profound and treatment-resistant exhaustion characteristic of the condition.

2. Brain Fog and Cognitive Slowing

The brain is among the most metabolically demanding organs in the body, consuming roughly 20% of total energy production despite representing only 2% of body weight. 

Neurons depend almost entirely on mitochondrial ATP production for synaptic signalling, memory consolidation, and executive function.

When mitochondrial dysfunction reduces neuronal energy availability, the cognitive consequences are predictable: difficulty concentrating, slowed processing speed, impaired working memory, and the subjective experience of mental cloudiness commonly described as brain fog. 

These symptoms frequently accompany chronic fatigue and are often dismissed as psychological rather than recognised as markers of cellular energy insufficiency.

3. Poor Exercise Tolerance and Slow Recovery

Skeletal muscle is heavily reliant on mitochondrial ATP production during sustained physical activity. 

In individuals with compromised mitochondrial function, the capacity to sustain aerobic exercise is reduced, the onset of muscular fatigue is earlier, and the recovery period following exertion is significantly prolonged.

A hallmark feature of mitochondrial dysfunction in this context is post-exertional malaise: a worsening of symptoms following physical or cognitive effort that can last hours or days. 

This is distinct from normal delayed-onset muscle soreness and reflects the cell’s inability to replenish ATP at the rate required by the activity.

4. Sleep Disturbance Despite Fatigue

One of the more counterintuitive manifestations of mitochondrial dysfunction is the coexistence of profound fatigue with disrupted or non-restorative sleep. 

Mitochondria play a role in regulating the cellular processes that govern circadian rhythm and sleep architecture. When mitochondrial function is impaired, the energy-dependent processes involved in sleep regulation, including the clearance of metabolic waste products from the brain during deep sleep, are also affected.

The result is a pattern in which individuals feel exhausted but cannot achieve the deep, restorative sleep that would normally support recovery, creating a self-reinforcing cycle of energy deficit and sleep disruption.

5. Heightened Sensitivity to Stress

The stress response is energetically expensive. Activating the hypothalamic-pituitary-adrenal axis, releasing cortisol, and mounting an immune response all require substantial ATP. 

In individuals with mitochondrial dysfunction, the cellular energy reserves available to support the stress response are already diminished. 

The result is a reduced stress threshold: what would be a manageable stressor for a person with healthy mitochondrial function becomes disproportionately taxing for someone whose cells are operating at reduced energy capacity.

6. Muscle Weakness and Pain Without Obvious Cause

Mitochondrial dysfunction in skeletal and cardiac muscle manifests as unexplained muscular weakness, cramping, or diffuse pain that is not explained by injury or overuse. 

When muscle cells cannot produce adequate ATP, contractile function is impaired and lactic acid accumulates more rapidly during even modest physical demands.

In more significant cases, mitochondrial myopathy is a recognised clinical condition characterised by muscle weakness driven specifically by impaired mitochondrial energy production. 

Milder degrees of the same underlying dysfunction may produce the non-specific muscle discomfort and weakness that many people with chronic fatigue experience without a formal diagnosis.

7. Accelerated Biological Ageing and Reduced Cellular Repair

Mitochondria are central to the processes of cellular repair and renewal. ATP is required for DNA repair, protein synthesis, and the maintenance of cellular membrane integrity. 

When mitochondrial dysfunction reduces energy availability, these maintenance processes are deprioritised, and the rate of cellular deterioration accelerates.

This contributes to a discrepancy between chronological age and biological age: individuals with significant mitochondrial dysfunction often show markers of accelerated cellular ageing relative to their years. 

Telomere shortening, increased oxidative damage, and declining tissue regenerative capacity are all associated with chronic mitochondrial insufficiency.

Targeting Mitochondrial Health From Different Angles

Scientific interest in mitochondrial dysfunction as a driver of chronic disease and accelerated ageing has grown substantially over the past two decades. 

Several research compounds are particularly relevant to mitochondrial health, each targeting different aspects of mitochondrial biology.

• SS-31

SS-31 (Elamipretide) is a mitochondria-targeted peptide that concentrates selectively at the inner mitochondrial membrane, where it binds to cardiolipin, a phospholipid essential for the structural integrity and function of the electron transport chain.

A study published in the Journal of the American College of Cardiology (Daubert et al., 2017) investigated SS-31 in patients with heart failure with preserved ejection fraction, a condition strongly associated with mitochondrial dysfunction. 

The study found that SS-31 improved exercise capacity and quality of life measures, consistent with a meaningful improvement in mitochondrial efficiency in metabolically demanding tissue.

By stabilising cardiolipin and reducing electron leak within the ETC, SS-31 supports more efficient ATP production and reduces the oxidative damage that accumulates when the electron transport chain operates under stress.

SS-31 Peptide Pen

• MOTS-C

MOTS-C is a peptide encoded within mitochondrial DNA itself, making it one of the few known mitochondria-derived signalling peptides. 

Research has documented its role in regulating insulin sensitivity, glucose metabolism, and cellular energy homeostasis through activation of the AMPK pathway.

A study published in Cell Metabolism (Lee et al., 2015) established MOTS-C as a regulator of metabolic homeostasis, demonstrating that MOTS-C administration in mice improved insulin sensitivity and reduced diet-induced obesity through its effects on cellular energy sensing. 

The study identified MOTS-C as a mitochondrial signal that communicates the cell’s energy status to the nucleus, representing a novel pathway for metabolic regulation.

For individuals whose fatigue has a metabolic component, MOTS-C‘s role in mitochondrial signalling and energy regulation makes it a particularly relevant compound in the context of mitochondrial dysfunction research.

MOTS-c Peptide Pen

NAD+

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every cell and is essential for the function of the electron transport chain. 

NAD+ acts as an electron carrier within the ETC, and its availability directly determines the efficiency of oxidative phosphorylation and ATP synthesis. 

NAD+ levels decline significantly with age and under conditions of chronic stress, directly contributing to reduced mitochondrial efficiency.

Beyond its role in energy production, NAD+ is a required substrate for sirtuins, a family of proteins that regulate mitochondrial biogenesis, DNA repair, and cellular stress responses. Research has documented that restoring NAD+ levels supports mitochondrial function and reduces markers of cellular ageing across multiple tissue types.

NAD+ Pen

DN Lab Research also offers a dedicated Cellular Repair and Energy Bundle (NAD+, MOTS-C, SS-31) for those looking to address mitochondrial dysfunction across multiple pathways simultaneously.

Think Your Fatigue May Have a Deeper Cause?

Persistent fatigue, brain fog, and poor recovery are not simply signs of a busy life. For many people, they reflect a genuine biological problem at the cellular level. 

Understanding whether mitochondrial dysfunction is contributing to how you feel, and what to do about it, requires expert input rather than general advice.

The DN Lab Research team offers tailored, 1:1 consultations with our Peptide Therapy specialists who understand mitochondrial biology, cellular energy research, and how to design a protocol suited to your specific goals and health profile. 

Schedule your 1:1 consultation

Frequently Asked Questions (FAQs)

What is mitochondrial dysfunction?

Mitochondrial dysfunction describes a reduction in the efficiency or capacity of mitochondria to perform their normal functions, most critically the production of ATP through oxidative phosphorylation. When mitochondria underperform, every biological process that depends on cellular energy is affected, from muscle contraction and cognitive function to immune response and tissue repair.

Can mitochondrial dysfunction cause chronic fatigue?

Yes. Reduced ATP production directly reduces the energy available to every cell in the body. When this reduction is significant or widespread, the result is a persistent fatigue that does not respond to rest in the way normal tiredness does. Research has documented reduced mitochondrial complex activity in patients with chronic fatigue syndrome, supporting mitochondrial dysfunction as a genuine biological contributor to chronic fatigue states.

What is the role of NAD+ in mitochondrial function?

NAD+ is a coenzyme that functions as an electron carrier within the mitochondrial electron transport chain, directly enabling ATP synthesis. NAD+ is also required by sirtuins, which regulate mitochondrial biogenesis and repair. NAD+ levels decline with age and under chronic stress, and this decline is one of the most well-documented contributors to age-related mitochondrial dysfunction.

What does MOTS-C do for mitochondrial health?

MOTS-C is a peptide encoded within mitochondrial DNA that acts as a metabolic signalling molecule, communicating the cell’s energy status to the nucleus. Research has demonstrated that MOTS-C activates the AMPK pathway, improving insulin sensitivity and glucose metabolism. In the context of mitochondrial dysfunction, MOTS-C’s role in restoring metabolic signalling makes it a relevant research compound for addressing the metabolic dimension of cellular energy failure.

How does SS-31 support mitochondrial function?

SS-31 concentrates at the inner mitochondrial membrane, where it binds to cardiolipin and stabilises the structural environment of the electron transport chain. By reducing electron leak and oxidative damage at this critical site, SS-31 supports more efficient ATP production and reduces the ROS accumulation that drives progressive mitochondrial deterioration.

Is mitochondrial dysfunction reversible?

In many cases, particularly where dysfunction is driven by modifiable factors such as oxidative stress, NAD+ depletion, or chronic inflammation, meaningful improvements in mitochondrial function are achievable with targeted intervention. The extent of reversibility depends on the severity of the underlying dysfunction, how long it has been present, and the individual’s overall biological resilience. Early identification and a multi-target approach to support produces the best outcomes.

How do I know if my fatigue is linked to mitochondrial dysfunction?

The pattern of symptoms described in this article, particularly fatigue that does not resolve with rest, brain fog, poor exercise tolerance, and slow recovery, points toward a cellular energy problem rather than a simple lifestyle one. Formal assessment, including relevant biomarkers and a full health history, is the most reliable way to identify mitochondrial dysfunction as a contributing factor. A specialist consultation provides the most targeted starting point.

Written by Elizabeth Sogeke, BSc Genetics, MPH

Elizabeth is a science and medical writer with a background in Genetics and Public Health. She holds a BSc in Genetics and a Master’s in Public Health (MPH), with a focus on mitochondrial science, metabolic health, and healthy aging. Over the past several years, she has worked with leading peptide research laboratories and functional medicine clinics, creating trusted, clinically-informed content that bridges the latest developments in peptide and longevity research with real-world applications.